Invisalign Itero


<< Back

Kevin Conroy

Independent Director


2009 - Present CEO and Chairman of the Board (2014), Exact Sciences
  Corp. (molecular diagnostics company) 
2005 - 2008 President and CEO, Third Wave Technologies, Inc.
  (molecular diagnostics company) 
2004 - 2005 General Counsel, Third Wave Technologies, Inc.
  (molecular diagnostics company) 
Prior Various Leadership Positions at GE Healthcare
  (medical technology company) 

Other Board Positions
Adaptive Biotechnologies Corporation (2019-2023)
Epizyme, Inc. (2017-2022)
CM Life Sciences II Inc. (2021)
SomaLogic, Inc. (2021)
Arya Sciences Acquisition Corp. (2018-2020)

Notable Experience and Key Board Contributions

  • Mr. Conroy has extensive experience creating stockholder value as a business, legal, corporate strategy, and executive leader and has significant experience in the healthcare and the molecular diagnostics industries.
  • At Exact Sciences, Mr. Conroy has developed Cologuard and the company has grown to $2.5B in revenue while serving 4 million patients.
  • At Third Wave, Mr. Conroy developed and brought a novel cervical cancer screening test, Cervista, to patients.

B.S. in Electrical Engineering from Michigan State University
J.D. from the University of Michigan Law School


Data Provided by Refinitiv. Minimum 15 minutes delayed.